751d SVR Results of Prove3, a Phase 2B Clinical Trial Assessing Safety and Efficacy of Telaprevir in Hepatitis C Genotype-1-Infected Patients with Prior Non-Response, Viral Breakthrough or Relapse to Peginterferon-Alfa-2a/B and Ribavirin Therapy

✍ Scribed by Adrian M. Di Bisceglie; Andrew M.J. Muir; Nathalie Adda; Ira M. Jacobson; Nezam H. Afdhal; E. Jenny Heathcote; Stefan Zeuzem; Henk W. Reesink; Norah Terrault; Mohammad Bsharat; Shelley George; Michael P. Manns; John McHutchison

• Book ID: 119430376
• Publisher: Elsevier Science
• Year: 2009
• Tongue: English
• Weight: 146 KB
• Volume: 136
• Category: Article
• ISSN: 0016-5085
• DOI: 10.1016/s0016-5085(09)60519-9